Literature DB >> 19932923

Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa.

Juan L Vivero-Escoto1, Igor I Slowing, Victor S-Y Lin.   

Abstract

A series of organically functionalized, MCM-41 type mesoporous silica nanoparticle materials (PAP-LP-MSN and AP-PAP-MSN) with different pore sizes (5.7 nm and 2.5 nm, respectively) were synthesized and characterized. We selectively decorated the exterior particle surface of PAP-LP-MSN and the interior pore surface of AP-PAP-MSN with an oligonucleotide intercalating phenanthridinium functionality. While phenanthridinium itself is a cell membrane impermeable molecule, we demonstrated that both phenanthridinium-immobilized PAP-LP-MSN and AP-PAP-MSN materials could indeed be internalized by live human cervical cancer cells (HeLa). We discovered that the PAP-LP-MSN nanoparticles with the phenanthridium groups located on the exterior surface were able to bind to cytoplasmic oligonucleotides, such as messenger RNAs, of HeLa cells resulting in severe cell growth inhibition. In contrast, the cytotoxicity of AP-PAP-MSN, where the same oligonucleotide intercalating molecules were anchored inside the pores, was significantly lowered upon the endocytosis by HeLa cells. We envision that this approach of combining the selective functionalization of the two different surfaces (exterior particle and interior pore surfaces) with morphology control of mesoporous silica nanoparticles would lead to a new generation of nanodevices with tunable biocompatibility and cell membrane trafficking properties for many biomedical applications. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932923     DOI: 10.1016/j.biomaterials.2009.11.009

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

1.  Uptake and cellular distribution, in four plant species, of fluorescently labeled mesoporous silica nanoparticles.

Authors:  Dequan Sun; Hashmath I Hussain; Zhifeng Yi; Rainer Siegele; Tom Cresswell; Lingxue Kong; David M Cahill
Journal:  Plant Cell Rep       Date:  2014-05-13       Impact factor: 4.570

Review 2.  The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.

Authors:  Robert Roggers; Shrey Kanvinde; Suthida Boonsith; David Oupický
Journal:  AAPS PharmSciTech       Date:  2014-05-29       Impact factor: 3.246

3.  Assessment of myeloperoxidase activity by the conversion of hydroethidine to 2-chloroethidium.

Authors:  Ghassan J Maghzal; Katie M Cergol; Sudhir R Shengule; Cacang Suarna; Darren Newington; Anthony J Kettle; Richard J Payne; Roland Stocker
Journal:  J Biol Chem       Date:  2014-01-16       Impact factor: 5.157

Review 4.  Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications.

Authors:  Juan L Vivero-Escoto; Yu-Tzu Huang
Journal:  Int J Mol Sci       Date:  2011-06-10       Impact factor: 5.923

5.  Preparation and In-vitro Evaluation of Rifampin-loaded Mesoporous Silica Nanoaggregates by an Experimental Design.

Authors:  Meysam Mohseni; Kambiz Gilani; Zohreh Bahrami; Noushin Bolourchian; Seyed Alireza Mortazavi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

6.  Preparation and characterization of rifampin loaded mesoporous silica nanoparticles as a potential system for pulmonary drug delivery.

Authors:  Meysam Mohseni; Kambiz Gilani; Seyed Alireza Mortazavi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

7.  Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.

Authors:  Bo Liu; Li Han; Junyan Liu; Shumei Han; Zhen Chen; Lixi Jiang
Journal:  Int J Nanomedicine       Date:  2017-01-31

Review 8.  Possible role of nanocarriers in drug delivery against cervical cancer.

Authors:  Swati Gupta; Manish K Gupta
Journal:  Nano Rev Exp       Date:  2017-07-07

9.  Paclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatment.

Authors:  Xiaolong Tang; Shuyu Cai; Rongbo Zhang; Peng Liu; Hongbo Chen; Yi Zheng; Leilei Sun
Journal:  Nanoscale Res Lett       Date:  2013-10-17       Impact factor: 4.703

10.  Effects of silica-gentamicin nanohybrids on osteogenic differentiation of human osteoblast-like SaOS-2 cells.

Authors:  Wei He; Dina A Mosselhy; Yudong Zheng; Qingling Feng; Xiaoning Li; Xing Yang; Lina Yue; Simo-Pekka Hannula
Journal:  Int J Nanomedicine       Date:  2018-02-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.